Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments (POSITIVE)
Primary Prevention of MACE With Standard and Intensive Statin Treatment in Hypercholesterolemia Patients With Concomitant Diabetes and Hypertension
Sponsor: Positive Trial Group
Terminated
With recommendation from IDMC, Steering Committee terminated this trial due to ethical concerns raised by J-ART study.
Other Hypercholesterolemia trials with similar outcome
This NA trial investigates Hypercholesterolemia and Hypertension and is currently terminated or withdrawn. Positive Trial Group leads this study, which shows 10 recorded versions since 2010 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Nov 2020 [monthly]
Terminated NA
-
May 2018 — Jun 2018 [monthly]
Terminated NA
-
Aug 2017 — May 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Positive Trial Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ageo, Japan , Akishima, Japan , Amagasaki, Japan , Amakusa, Japan , Anan, Japan , Aomori, Japan , Ashigara-kami Gun, Japan , Ashigarakami Gun, Japan , Aso, Japan , Atsugi, Japan and 159 more locations